This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Most of this program has been concerned with mass casualties resulting from nuclear weapons. My responsibility is to describe briefly the medical problems posed by two other methods of producing casualties; namely, chemical and biological warfare. Neither is associated with physical destruction. Using either chemical or biological warfare agents, an enemy could induce illness or death in varying numbers of personnel. Having admitted this capability, there then devolves on us, as a part of our basic medical responsibility, the requirement to be able to handle such attacks.
About the only real similarity chemical and biological warfare agents have is in the method of dissemination. The most likely use of either would be with various devices capable of producing large numbers of very small air-borne particles or aerosols. The entry of these particles into the body is through the respiratory tract or, in the case of certain chemical agents, through the
Tigertt WD. MEDICAL ASPECTS OF DEFENSE AGAINST CHEMICAL AND BIOLOGICAL WARFARE. JAMA. 1959;171(2):217–220. doi:10.1001/jama.1959.73010200040014k
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: